EmphyClear COPD Oral Spray (70% Lower Steroid Prescription - In Final Clinicals)

circular saw
Notify Me
Manufacturer: EmphyCorp

EmphyClear 70% Lower Steroid COPD/Asthma Spray (Prescription) 8 Drug Patents

    - Completed US Clinicals for a Patented 70% lower steroid version of an well known, off-patent COPD/Asthma Spray that meets the new US FDA safety requirement and got equal or better efficacy 

    - Final US Clinical Trials are planned for early 2019

    - China Clinical Trials are planned for early 2019